<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fphar.2017.00128</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Hydrogen Sulfide Inhibits High-Salt Diet-Induced Myocardial Oxidative Stress and Myocardial Hypertrophy in Dahl Rats</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Huang</surname> <given-names>Pan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/400889/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Shen</surname> <given-names>Zhizhou</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/421439/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Yu</surname> <given-names>Wen</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/421447/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Huang</surname> <given-names>Yaqian</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/421451/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Tang</surname> <given-names>Chaoshu</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/19136/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Du</surname> <given-names>Junbao</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/40308/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Jin</surname> <given-names>Hongfang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/400195/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Pediatrics, Peking University First Hospital</institution> <country>Beijing, China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Physiology and Pathophysiology, Peking University Health Science Centre</institution> <country>Beijing, China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Key Laboratory of Molecular Cardiology, Ministry of Education, Peking University</institution> <country>Beijing, China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: <italic>Minghan Wang, Phanes Therapeutics, USA</italic></p></fn>
<fn fn-type="edited-by"><p>Reviewed by: <italic>Valentina Vellecco, University of Naples Federico II, Italy; Fiorentina Roviezzo, University of Naples Federico II, Italy</italic></p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x002A;Correspondence: <italic>Hongfang Jin, <email>jinhongfang51@126.com</email></italic></p></fn>
<fn fn-type="other" id="fn002"><p>This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>03</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>08</volume>
<elocation-id>128</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>12</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>03</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2017 Huang, Shen, Yu, Huang, Tang, Du and Jin.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Huang, Shen, Yu, Huang, Tang, Du and Jin</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>The study aimed to examine the protective effect of hydrogen sulfide (H<sub>2</sub>S) on high-salt-induced oxidative stress and myocardial hypertrophy in salt-sensitive (Dahl) rats. Thirty male Dahl rats and 40 SD rats were included in the study. They were randomly divided into Dahl control (Dahl + NS), Dahl high salt (Dahl + HS), Dahl + HS + NaHS, SD + NS, SD + HS, SD + HS + NaHS, and SD + HS + hydroxylamine (HA). Rats in Dahl + NS and SD + NS groups were given chow with 0.5% NaCl and 0.9% normal saline intraperitoneally daily. Myocardial structure, &#x03B1;-myosin heavy chain (&#x03B1;-MHC) and &#x03B2;-myosin heavy chain (&#x03B2;-MHC) expressions were determined. Endogenous myocardial H<sub>2</sub>S pathway and oxidative stress in myocardial tissues were tested. Myocardial H<sub>2</sub>S pathway was downregulated with myocardial hypertrophy featured by increased heart weight/body weight and cardiomyocytes cross-sectional area, decreased &#x03B1;-MHC and increased &#x03B2;-MHC expressions in Dahl rats with high-salt diet (all <italic>P</italic> &#x003C; 0.01), and oxidative stress in myocardial tissues was significantly activated, demonstrated by the increased contents of hydroxyl radical, malondialdehyde and oxidized glutathione and decreased total antioxidant capacity, carbon monoxide, catalase, glutathione, glutathione peroxidase, superoxide dismutase (SOD) activities and decreased SOD1 and SOD2 protein expressions (<italic>P</italic> &#x003C; 0.05, <italic>P</italic> &#x003C; 0.01). However, H<sub>2</sub>S reduced myocardial hypertrophy with decreased heart weight/body weight and cardiomyocytes cross-sectional area, increased &#x03B1;-MHC, decreased &#x03B2;-MHC expressions and inhibited oxidative stress in myocardial tissues of Dahl rats with high-salt diet. However, no significant difference was found in H<sub>2</sub>S pathway, myocardial structure, &#x03B1;-MHC and &#x03B2;-MHC protein and oxidative status in myocardial tissues among SD + NS, SD + HS, and SD + HS + NaHS groups. HA, an inhibitor of cystathionine &#x03B2;-synthase, inhibited myocardial H<sub>2</sub>S pathway (<italic>P</italic> &#x003C; 0.01), and stimulated myocardial hypertrophy and oxidative stress in SD rats with high-salt diet. Hence, H<sub>2</sub>S inhibited myocardial hypertrophy in high salt-stimulated Dahl rats in association with the enhancement of antioxidant capacity, thereby inhibiting oxidative stress in myocardial tissues.</p>
</abstract>
<kwd-group>
<kwd>hydrogen sulfide</kwd>
<kwd>high salt diet</kwd>
<kwd>salt sensitive hypertension</kwd>
<kwd>myocardial hypertrophy</kwd>
<kwd>oxidative stress</kwd>
</kwd-group>
<contract-num rid="cn001">81622004</contract-num>
<contract-num rid="cn001">81500325</contract-num>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></contract-sponsor>
<counts>
<fig-count count="6"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="44"/>
<page-count count="11"/>
<word-count count="0"/>
</counts>
</article-meta>
</front>
<body>
<sec><title>Introduction</title>
<p>Myocardial hypertrophy is a common cardiovascular pathology, which is an independent risk factor of cardiovascular disease (<xref ref-type="bibr" rid="B3">Cramariuc and Gerdts, 2016</xref>). Clinical and basic studies have shown that long-term high-salt intake is an independent risk factor of myocardial hypertrophy (<xref ref-type="bibr" rid="B25">Mimran and du Cailar, 2008</xref>; <xref ref-type="bibr" rid="B18">Li et al., 2009</xref>). The study showed that salt-sensitive hypertensive patients were more prone to develop myocardial hypertrophy and cardiovascular events (<xref ref-type="bibr" rid="B2">Chamarthi et al., 2010</xref>). Previous studies suggested that the potential mechanisms underlying high-salt-induced myocardial hypertrophy mainly included hemodynamic changes, sodium serum levels, increased sodium influx of cardiomyocytes, activation of cardiac renin-angiotensin-aldosterone system (RAAS) and activation of cardiac sympathetic nervous system (<xref ref-type="bibr" rid="B6">Gallo et al., 1990</xref>; <xref ref-type="bibr" rid="B5">Galderisi et al., 1991</xref>; <xref ref-type="bibr" rid="B12">Harmsen and Leenen, 1992</xref>; <xref ref-type="bibr" rid="B17">Le Corvoisier et al., 2010</xref>; <xref ref-type="bibr" rid="B13">He and Macgregor, 2012</xref>). However, the mechanism for high-salt-induced myocardial hypertrophy still remains unclear.</p>
<p>Endogenous hydrogen sulfide (H<sub>2</sub>S) can be produced with L-cysteine as the substrate, catalyzed by the key enzymes cystathionine &#x03B2;-synthase (CBS) and cystathionine &#x03B3;-lyase (CSE), and it can also be produced with 3-mercaptopyruvate as the substrate, catalyzed by mercaptopyruvate sulfurtransferase (MPST). The three enzymes are richly expressed in the cardiovascular system (<xref ref-type="bibr" rid="B9">Geng et al., 2004b</xref>). Studies showed that H<sub>2</sub>S had a protective effect on myocardial injury in different diseases (<xref ref-type="bibr" rid="B20">Liu et al., 2014</xref>; <xref ref-type="bibr" rid="B31">Shen et al., 2015</xref>). H<sub>2</sub>S protected the myocardium and cardiac function by inhibiting inflammatory reaction and apoptosis, etc (<xref ref-type="bibr" rid="B34">Sodha et al., 2009</xref>; <xref ref-type="bibr" rid="B35">Su et al., 2009</xref>; <xref ref-type="bibr" rid="B36">Wei et al., 2010</xref>; <xref ref-type="bibr" rid="B21">Lu et al., 2013</xref>; <xref ref-type="bibr" rid="B39">Yang et al., 2014</xref>). Furthermore, our previous studies demonstrated that down-regulation of renal H<sub>2</sub>S/CBS pathway induced by high salt led to the development of hypertension, and H<sub>2</sub>S could improve aortic structural remodeling and reduce the high salt-induced renal injury in Dahl rats (<xref ref-type="bibr" rid="B14">Huang et al., 2015</xref>, <xref ref-type="bibr" rid="B15">2016</xref>), suggesting that the effect of H<sub>2</sub>S on the function and structure of aorta and kidney participated in the protective regulation of H<sub>2</sub>S on the myocardial hypertrophy. However, it is unclear whether endogenous H<sub>2</sub>S pathway was involved in the pathogenesis of high salt-induced myocardial hypertrophy.</p>
<p>Considering that the oxidative stress injury is a key pathological basis of myocardial hypertrophy, we focused on the myocardial oxidative stress as the target in salt-sensitive animal model and designed the present study to explore the role of H<sub>2</sub>S in myocardial hypertrophy induced by high-salt and the possible mechanism underlying myocardial hypertrophy in rats.</p>
</sec>
<sec id="s1" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec><title>Animal Protocol</title>
<p>Thirty male Dahl rats and 40 SD rats (Charles River Laboratory Animal Technology Co., Ltd., China; license number: SCXK 2012-0001) at 6 weeks of age were randomly divided into the following groups including Dahl control group (Dahl + NS), Dahl high salt group (Dahl + HS), Dahl high salt + NaHS group (Dahl + HS + NaHS), SD control group (SD + NS), SD high salt group (SD + HS), SD high salt + sodium hydrosulfide (NaHS) group (SD + HS + NaHS) and SD high salt + hydroxylamine (HA) group (SD + HS + HA). Rats in Dahl + NS and SD + NS groups were given chow with 0.5% sodium chloride (NaCl) and 0.9% saline by intraperitoneal injection daily. Rats in Dahl + HS and SD + HS groups were given chow with 8% NaCl and 0.9% saline by intraperitoneal injection daily. Rats in the Dahl + HS + NaHS and SD + HS + NaHS groups were given chow with 8% NaCl and 90 &#x03BC;mol/kg NaHS by intraperitoneal injection daily (<xref ref-type="bibr" rid="B32">Shi et al., 2007</xref>). Rats in the SD + HS + HA group were given chow with 8% NaCl and 12.5 mg/kg HA (an inhibitor of CBS) per day (<xref ref-type="bibr" rid="B11">Han et al., 2005</xref>) and NaHS and HA solutions were freshly prepared with 0.9% saline daily. All rats were housed in Animal Center of Peking University First Hospital, freely drinking water and food throughout the whole experiment. The rats were kept at 25&#x00B0;C constant temperature and circadian rhythm of 12 h/12 h. The animal experiment was approved by the Experimental Animal Ethics Committee of Peking University First Hospital and strictly followed the regulations and guidelines of experimental animals of Peking University First Hospital.</p>
</sec>
<sec><title>Measurement of Body Weight and Heart Weight</title>
<p>At the end of the experiment, the body weight of conscious and quiet rats was measured. The rats were anesthetized by intraperitoneal injection of 25% urethane at 1.25 g/kg body weight. After the chest was opened, the hearts were removed rapidly and the heart weight was measured.</p>
</sec>
<sec><title>Myocardial Pathology</title>
<p>Appropriately 2 mm of cardiac cross-section tissue was taken, fixed in 4% paraformaldehyde and paraffin-embedded. Then, 5 &#x03BC;m of slice was taken for hematoxylin-eosin (HE) staining. Image acquisition and quantitative analysis of cardiomyocyte HE staining were performed by Leica Q550CW Image Processing and Analysis System. Each sample was randomly selected three fields from the left ventricular tissue, which were used to calculate the size of myocardial cells. The tissue samples of paraffin sections were put in xylene for 5 min, totally three times, then 100, 95, and 75% ethanol for 5 min separately, deionized water for 5 min, totally three times and then stained with Dio solution of 25 &#x03BC;mol/L overnight at 4&#x00B0;C. Fluorescence image acquisition and analysis were performed by using a laser scanning confocal microscope (Olympus, Japan). Three fields were randomly taken from each sample, and approximately 100 cells were quantitatively analyzed for cell size (<xref ref-type="bibr" rid="B38">Wu et al., 2012</xref>).</p>
</sec>
<sec><title>Real-Time Quantitative Polymerase Chain Reaction (RT-PCR)</title>
<p>Total ribonucleic acid (RNA) was extracted from myocardial tissues by Trizol method. The purity and concentration of the total RNA were determined by the quantitative detection of nucleic acid protein. Two microgram of total RNA was used for complementary deoxyribonucleic acid (cDNA) synthesis by reverse transcription. cDNA synthesis conditions included 25 &#x03BC;L of reaction system for denaturation at 70&#x00B0;C for 5 min, and then at 42&#x00B0;C reaction for 60 min in PCR instrument. Twenty-five microliter of mixture was expanded in an ABI Prism 7300 instrument (Applied Biosystems, Foster, CA, USA). RT-PCR reaction conditions were set at 95&#x00B0;C pre-denaturation for 10 min, 95&#x00B0;C denaturation for 15 s, 60&#x00B0;C annealing for 1 min, and 72&#x00B0;C polymerization extension for 30 s, with a total of 40 cycles. &#x03B2;-actin was used as an internal reference for the calibration. The primers were synthesized by Sangon Biotech (Shanghai) Co., Ltd. The primer sequences were shown in <bold>Table <xref ref-type="table" rid="T1">1</xref></bold>. The ABI prism 7300 system software was for Ct and 2<sup>-&#x0394;&#x0394;t</sup> data analysis (<xref ref-type="bibr" rid="B22">Luo et al., 2013</xref>).</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Sequence of targeted gene and &#x03B2;-actin cDNA primer and Taqman</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left">Target</th>
<th valign="top" align="center">primer</th>
<th valign="top" align="left">Sequence (5&#x2032;-3&#x2032;)</th>
<th valign="top" align="center">Product</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Rat CBS</td>
<td valign="top" align="center">Forward</td>
<td valign="top" align="left">CTCCGGGAGAAGGGTTTTGA</td>
<td valign="top" align="center">81 bp</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">Reverse</td>
<td valign="top" align="left">CATGTTCCCGAGAGTCACCAT</td></tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">TaqMan</td>
<td valign="top" align="left">AGGCACCTGTGGTCAACGAGTCTGG</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">probe</td>
</tr>
<tr>
<td valign="top" align="left">Rat CSE</td>
<td valign="top" align="center">Forward</td>
<td valign="top" align="left">GCTGAGAGCCTGGGAGGATA</td>
<td valign="top" align="center">92 bp</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">Reverse</td>
<td valign="top" align="left">TCACTGATCCCGAGGGTAGCT</td></tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">TaqMan</td>
<td valign="top" align="left">CTGAGCTTCCAGCAATCATGACCCATG</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">probe</td>
</tr>
<tr>
<td valign="top" align="left">Rat MPST</td>
<td valign="top" align="center">Forward</td>
<td valign="top" align="left">CGGCGCTTCCAGGTAGTG</td>
<td valign="top" align="center">131 bp</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">Reverse</td>
<td valign="top" align="left">CTGGTCAGGAATTCAGTGAATGG</td></tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">TaqMan</td>
<td valign="top" align="left">CCGCGCAGCTGGCCGTTT</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">probe</td>
</tr>
<tr>
<td valign="top" align="left">Rat &#x03B2;-actin</td>
<td valign="top" align="center">Forward</td>
<td valign="top" align="left">ACCCGCGAGTACAACCTTCTT</td>
<td valign="top" align="center">80 bp</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">Reverse</td>
<td valign="top" align="left">TATCGTCATCCATGGCGAACT</td></tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">TaqMan</td>
<td valign="top" align="left">CCTCCGTCGCCGGTCCACAC</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center">probe</td></tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec><title>Western Blot Assay</title>
<p>Myocardial tissues were ground into homogenate according to the mass volume ratio 1:10 (mg/&#x03BC;L) adding 1 &#x00D7; tissue lysate, and then the homogenate was centrifuged for 10 min at 4&#x00B0;C for supernatant. The supernatant was collected and added into the same volume of 2 &#x00D7; loading buffer at 100&#x00B0;C for 5 min. Each channel was added with equal amount of protein mixture for polyacrylamide gel electrophoresis, transferred into membrane. The primary antibodies including &#x03B1;-myosin heavy chain (&#x03B1;-MHC; 1:200, Santa Cruz Biotechnology, USA), &#x03B2;-MHC (1:200, Santa Cruz Biotechnology, USA), CBS (1:2000, Santa Cruz Biotechnology, USA), CSE (1:500, Sigma, USA), MPST (1:4000, Santa Cruz Biotechnology, USA), superoxide dismutase 1 (SOD1; 1:5000, Stressgen, USA), SOD2 (1:5000, Stressgen, USA), &#x03B2;-actin (1:2000, Santa Cruz Biotechnology, USA), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 1:2000, Kangcheng, Shanghai, China) were added into membrane overnight at 4&#x00B0;C for incubation, and then washed by TTBS for 10 min/time of total of four times, with secondary antibodies for 1 h at room temperature for full incubation. AlphaImager gel imaging system was used to scan the protein band and measure the optical density of the protein band, and &#x03B2;-actin and GAPDH as internal reference protein were used to correct (<xref ref-type="bibr" rid="B22">Luo et al., 2013</xref>).</p>
</sec>
<sec><title>H<sub>2</sub>S Content in Myocardial Tissues Assay</title>
<p>Appropriate amount of myocardial tissues was weighed and placed in 1.5 ml of EP tube, according to the mass volume ratio (1/10) with phosphate buffer saline (PBS) solution (pH7.2, 50 mmol/L), then myocardial tissues were ground into homogenate which was centrifuged at 12000 g for 10 min at 4&#x00B0;C for the supernatant, and still then the supernatant was measured to protein content. The H<sub>2</sub>S content in the supernatant was determined using a Free Radical Detection Analyzer TBR4100 (World Precision Instruments, Shanghai, China) (<xref ref-type="bibr" rid="B4">Fox et al., 2012</xref>). At First, a 100 &#x03BC;m of ISO-H<sub>2</sub>S-100 sensor (ISO-H<sub>2</sub>S-100, WPI, Shanghai, China) was polarized in PBS buffer solution (pH 7.2, 50 mmol/L). The sensor could be calibrated as a stable reference current came out (usually 100&#x2013;2000 pA). Approximately 10 mm of the sensor tip was immersed into 20 ml of PBS buffer solution (pH 7.2, 50 mmol/L) until a steady current appeared on the display. Six different concentrations of sodium sulfide solution (1, 2, 4, 8, 16, and 32 &#x03BC;mol/L) prepared in PBS buffer were successively detected by the detecting probe. After each sample added, the current output rapidly increased to the plateau. As long as the current reached the plateau, the next sample could be detected. The calibration curve was prepared from the signal output (pA) and the corresponding H<sub>2</sub>S concentration (&#x03BC;M). The length of immersion was about 10 mm for each sample. The H<sub>2</sub>S content in each sample could be calculated according to the calibration curve of pA-H<sub>2</sub>S concentration.</p>
</sec>
<sec><title>Oxidative Stress Indices in Myocardial Tissues Assay</title>
<p>Appropriate amount of myocardial tissues was put into PBS buffer (pH 7.2, 10 mmol/L) according to the mass ratio of 1:10 (mg/&#x03BC;l), and was fully ground into homogenate which was centrifuged at 12000 <italic>g</italic> for 10 min at 4&#x00B0;C for the supernatant. The activities of SOD, catalase (CAT), glutathione peroxidase (GSH-PX), and oxidized glutathione (GSSG) were determined by biochemical colorimetry. Glutathione (GSH), malondialdehyde (MDA), hydroxyl radical (&#x22C5;OH), carbon monoxide (CO), and total antioxidant capacity (T-AOC) were measured by biochemical colorimetry. The experimental procedure was strictly carried out according to the kit (Nanjing Jiancheng Biology Engineering Research Institute, China).</p>
</sec>
<sec><title>Statistical Analysis</title>
<p>The data statistical analysis was performed using ABI SPSS 13.0 software. The results was expressed as mean &#x00B1; standard error (mean &#x00B1; SEM). The means among more than 2 groups were compared using one-way ANOVA. <italic>P</italic> &#x003C; 0.05 was significant.</p>
</sec>
</sec>
<sec><title>Results</title>
<sec><title>Effect of High-Salt Diet on H<sub>2</sub>S/CBS Pathway of Myocardial Tissues in Dahl Rats</title>
<p>Compared with rats in Dahl + NS group, H<sub>2</sub>S content of myocardial tissues was significantly decreased (<italic>P</italic> &#x003C; 0.01; <bold>Figure <xref ref-type="fig" rid="F1">1A</xref></bold>) with downregulated CBS mRNA and protein expression (<italic>P</italic> &#x003C; 0.01; <bold>Figures <xref ref-type="fig" rid="F1">1B1,C1</xref></bold>) and reduced CSE mRNA (<italic>P</italic> &#x003C; 0.01; <bold>Figure <xref ref-type="fig" rid="F1">1B2</xref></bold>), but CSE protein expression and MPST mRNA and protein expressions of myocardial tissues did not differ in Dahl + HS group rats (<italic>P</italic> > 0.05; <bold>Figures <xref ref-type="fig" rid="F1">1B3,C2,C3</xref></bold>). There was no obvious difference in H<sub>2</sub>S content and CBS, CSE and MPST mRNA and protein expressions of myocardial tissues among SD + NS group, SD + HS group and SD + HS + NaHS group rats (<italic>P</italic> > 0.05; <bold>Figures <xref ref-type="fig" rid="F2">2A&#x2013;C</xref></bold>). But, compared with SD rats, H<sub>2</sub>S content and CBS protein expression of myocardial tissues were significantly reduced (<italic>P</italic> &#x003C; 0.01; <bold>Figures <xref ref-type="fig" rid="F2">2A,C1</xref></bold>), whereas CBS mRNA, CSE and MPST mRNA and protein expressions did not change in SD rats treated with HA (<italic>P</italic> > 0.05; <bold>Figures <xref ref-type="fig" rid="F2">2B,C2,C3</xref></bold>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p><bold>The change in H<sub>2</sub>S pathway of myocardial tissues in each group of Dahl rats. (A)</bold> H<sub>2</sub>S content of myocardial tissues in Dahl rats. <bold>(B1&#x2013;B3)</bold> CBS, MPST, and CSE mRNA expressions of myocardial tissues in Dahl rats. <bold>(C1&#x2013;C3)</bold> CBS, MPST, and CSE protein expressions of myocardial tissues in Dahl rats. The data are described as mean &#x00B1; SEM, <italic>n</italic> = 10, <sup>&#x2217;&#x2217;</sup><italic>P</italic> &#x003C; 0.01 versus Dahl + NS, <sup>##</sup><italic>P</italic> &#x003C; 0.01 versus Dahl + HS.</p></caption>
<graphic xlink:href="fphar-08-00128-g001.tif"/>
</fig>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p><bold>The change in H<sub>2</sub>S pathway of myocardial tissues in each group of SD rats. (A)</bold> H<sub>2</sub>S content of myocardial tissues in SD rats. <bold>(B1&#x2013;B3)</bold> CBS, MPST, and CSE mRNA expressions of myocardial tissues in SD rats. <bold>(C1&#x2013;C3)</bold> CBS, MPST, and CSE protein expressions of myocardial tissues in SD rat. The data are described as mean &#x00B1; SEM, <italic>n</italic> = 10, <sup>&#x0026;&#x0026;</sup><italic>P</italic> &#x003C; 0.01, <sup>&#x00A7;</sup> <italic>P</italic> &#x003C; 0.05, <sup>&#x00A7;&#x00A7;</sup> <italic>P</italic> &#x003C; 0.01 versus SD + HS.</p></caption>
<graphic xlink:href="fphar-08-00128-g002.tif"/>
</fig>
</sec>
<sec><title>Effect of H<sub>2</sub>S on High-Salt-Induced Myocardial Hypertrophy in Dahl + HS Group Rats</title>
<p>Compared with rats in Dahl + NS group, those in Dahl + HS group showed marked myocardial hypertrophy including increased heart weight/body weight (<italic>P</italic> &#x003C; 0.01; <bold>Figure <xref ref-type="fig" rid="F3">3A</xref></bold>) and cardiomyocyte cross-sectional area (<italic>P</italic> &#x003C; 0.01; <bold>Figures <xref ref-type="fig" rid="F3">3B1&#x2013;B4,C1&#x2013;C4</xref></bold>), decreased &#x03B1;-MHC protein, but increased &#x03B2;-MHC protein (<italic>P</italic> &#x003C; 0.01; <bold>Figures <xref ref-type="fig" rid="F3">3D1,D2</xref></bold>). However, compared with rats in Dahl + HS group, those in Dahl + HS + NaHS group exhibited lessened myocardial hypertrophy characterized by decreased heart weight/body weight (<italic>P</italic> &#x003C; 0.05; <bold>Figure <xref ref-type="fig" rid="F3">3A</xref></bold>), reduced cardiomyocyte cross-sectional area (<italic>P</italic> &#x003C; 0.01; <bold>Figures <xref ref-type="fig" rid="F3">3B1&#x2013;B4,C1&#x2013;C4</xref></bold>), increased &#x03B1;-MHC protein, but decreased &#x03B2;-MHC protein (<italic>P</italic> &#x003C; 0.05, <italic>P</italic> &#x003C; 0.01; <bold>Figures <xref ref-type="fig" rid="F3">3D1,D2</xref></bold>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p><bold>Myocardial structure change in each group of Dahl rats. (A)</bold> heart weight/body weight in Dahl rat. <bold>(B1&#x2013;B4)</bold> cardiomyocyte HE staining (400&#x00D7;) in Dahl rats. <bold>(C1&#x2013;C4)</bold> cardiomyocyte Dio staining (600&#x00D7;) in Dahl rats. <bold>(D1&#x2013;D2)</bold> &#x03B1;-MHC and &#x03B2;-MHC protein expressions of myocardial tissues in Dahl rats. The data are described as mean &#x00B1; SEM, <italic>n</italic> = 10, <sup>&#x2217;&#x2217;</sup><italic>P</italic> &#x003C; 0.01 versus Dahl + NS, <sup>#</sup><italic>P</italic> &#x003C; 0.05, <sup>##</sup><italic>P</italic> &#x003C; 0.01 versus Dahl + HS.</p></caption>
<graphic xlink:href="fphar-08-00128-g003.tif"/>
</fig>
</sec>
<sec><title>HA Induced Myocardial Hypertrophy in SD + HS Group Rats</title>
<p>There was no statistical difference in myocardial structure, and &#x03B1;-MHC and &#x03B2;-MHC protein expressions of myocardial tissues of rats among SD + NS group, SD + HS group and SD + HS + NaHS group (<italic>P</italic> > 0.05; <bold>Figures <xref ref-type="fig" rid="F4">4A&#x2013;D</xref></bold>). However, compared with those in rats of SD + HS group, ratio of heart weight/body weight and cardiomyocyte cross-sectional area were increased, &#x03B1;-MHC protein was downregulated but &#x03B2;-MHC protein expression was upregulated in myocardial tissues of rats in SD + HS + HA group (<italic>P</italic> &#x003C; 0.05, <italic>P</italic> &#x003C; 0.01; <bold>Figures <xref ref-type="fig" rid="F4">4A&#x2013;D</xref></bold>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption><p><bold>Myocardial structure change in each group of SD rats. (A)</bold> heart weight/body weight in SD rats. <bold>(B1&#x2013;B5)</bold> cardiomyocyte HE staining (400&#x00D7;) in SD rats. <bold>(C1&#x2013;C5)</bold> cardiomyocyte Dio staining (600&#x00D7;) in SD rats. <bold>(D1&#x2013;D2)</bold> &#x03B1;-MHC and &#x03B2;-MHC protein expressions of myocardial tissues in SD rats. The data are described as mean &#x00B1; SEM, <italic>n</italic> = 10, <sup>&#x00A7;</sup> <italic>P</italic> &#x003C; 0.05, <sup>&#x00A7;&#x00A7;</sup> <italic>P</italic> &#x003C; 0.01 versus SD + HS.</p></caption>
<graphic xlink:href="fphar-08-00128-g004.tif"/>
</fig>
</sec>
<sec><title>Effect of H<sub>2</sub>S on High-Salt-Induced Excessive Activation of Oxidative Stress of Myocardial Tissues in Dahl Rats</title>
<p>Compared with rats of Dahl + NS group, the levels of T-AOC, CO and GSH, the activities of CAT, GSH-Px and SOD (<italic>P</italic> &#x003C; 0.05, <italic>P</italic> &#x003C; 0.01; <bold>Figures <xref ref-type="fig" rid="F5">5A1&#x2013;A6</xref></bold>) and protein expressions of SOD1 and SOD2 were decreased (<italic>P</italic> &#x003C; 0.01; <bold>Figures <xref ref-type="fig" rid="F5">5B1,B2</xref></bold>), but the contents of &#x22C5;OH, MDA, and GSSG were obviously increased (<italic>P</italic> &#x003C; 0.05, <italic>P</italic> &#x003C; 0.01; <bold>Figures <xref ref-type="fig" rid="F5">5C1&#x2013;C3</xref></bold>) in the myocardial tissues of rats in Dahl + HS group. Compared with rats of Dahl + HS group, the levels of T-AOC, CO, and GSH, the activities of CAT, GSH-Px, and SOD (<italic>P</italic> &#x003C; 0.05; <bold>Figures <xref ref-type="fig" rid="F5">5A1&#x2013;A6</xref></bold>), and protein expressions of SOD1 and SOD2 were significantly increased (<italic>P</italic> &#x003C; 0.05, <italic>P</italic> &#x003C; 0.01; <bold>Figures <xref ref-type="fig" rid="F5">5B1,B2</xref></bold>), but the contents of &#x22C5;OH, MDA, and GSSG were significantly decreased (<italic>P</italic> &#x003C; 0.05; <bold>Figures <xref ref-type="fig" rid="F5">5C1&#x2013;C3</xref></bold>) in myocardial tissues of rats in Dahl + HS + NaHS group.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption><p><bold>Oxidative stress and antioxidant stress indices of myocardial tissues in each group of Dahl rats. (A1)</bold> T-AOC of myocardial tissues in Dahl rats. <bold>(A2)</bold> CO of myocardial tissues in Dahl rats. <bold>(A3)</bold> GSH myocardial tissues in Dahl rats. <bold>(A4)</bold> CAT activity of myocardial tissues in Dahl rats. <bold>(A5)</bold> GSH-Px activity of myocardial tissues in Dahl rats. <bold>(A6)</bold> SOD activity of myocardial tissues in Dahl rats. <bold>(B1,B2)</bold> SOD1 and SOD2 protein expressions of myocardial tissues in Dahl rats. <bold>(C1)</bold> &#x22C5;OH content of myocardial tissues in Dahl rats. <bold>(C2)</bold> MDA content of myocardial tissues in Dahl rats. <bold>(C3)</bold> GSSG content of myocardial tissues in Dahl rats. The data are described as mean &#x00B1; SEM, <italic>n</italic> = 10, <sup>&#x2217;</sup><italic>P</italic> &#x003C; 0.05, <sup>&#x2217;&#x2217;</sup><italic>P</italic> &#x003C; 0.01 versus Dahl + NS, <sup>#</sup><italic>P</italic> &#x003C; 0.05, <sup>##</sup><italic>P</italic> &#x003C; 0.01, versus Dahl + HS.</p></caption>
<graphic xlink:href="fphar-08-00128-g005.tif"/>
</fig>
</sec>
<sec><title>HA Activated Oxidative Stress of Myocardial Tissues in SD + HS Group Rats</title>
<p>There was no significant difference in the levels of T-AOC, CO and GSH, the activities of CAT, GSH-Px and SOD, protein expressions of SOD1 and SOD2 (<italic>P</italic> > 0.05; <bold>Figures <xref ref-type="fig" rid="F6">6A1&#x2013;A6,B1,B2</xref></bold>) as well as the contents of &#x22C5;OH, MDA, and GSSG of myocardial tissues (<italic>P</italic> > 0.05; <bold>Figures <xref ref-type="fig" rid="F6">6C1&#x2013;C3</xref></bold>) among SD + NS group, SD + HS group and SD + HS + NaHS group of rats. However, compared with those of SD + HS group, the levels of T-AOC, CO and GSH, the activities of CAT, GSH-Px and SOD as well as protein expressions of SOD1 and SOD2 were significantly decreased (<italic>P</italic> &#x003C; 0.05, <italic>P</italic> &#x003C; 0.01; <bold>Figures <xref ref-type="fig" rid="F6">6A1&#x2013;A6,B1,B2</xref></bold>), but the contents of &#x22C5;OH, MDA, and GSSG were obviously increased (<italic>P</italic> &#x003C; 0.05; <bold>Figures <xref ref-type="fig" rid="F6">6C1&#x2013;C3</xref></bold>) in the myocardial tissues of rats in SD + HS + HA group.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption><p><bold>Oxidative stress and antioxidant stress indices of myocardial tissues in each group of SD rats. (A1)</bold> T-AOC of myocardial tissues in SD rats. <bold>(A2)</bold> CO of myocardial tissues in SD rats. <bold>(A3)</bold> GSH of myocardial tissues in SD rats. <bold>(A4)</bold> CAT activity of myocardial tissues in SD rats. <bold>(A5)</bold> GSH-Px activity of myocardial tissues in SD rats. <bold>(A6)</bold> SOD activity of myocardial tissues in SD rats. <bold>(B1,B2)</bold> SOD1 and SOD2 protein expressions of myocardial tissues in SD rats. <bold>(C1)</bold> &#x22C5;OH content of myocardial tissues in SD rats. <bold>(C2)</bold> MDA content of myocardial tissues in SD rats. <bold>(C3)</bold> GSSG content of myocardial tissues in SD rats. The data are described as mean &#x00B1; SEM, <italic>n</italic> = 10, <sup>&#x00A7;</sup> <italic>P</italic> &#x003C; 0.05, <sup>&#x00A7;&#x00A7;</sup> <italic>P</italic> &#x003C; 0.01 versus SD + HS.</p></caption>
<graphic xlink:href="fphar-08-00128-g006.tif"/>
</fig>
</sec>
</sec>
<sec><title>Discussion</title>
<p>Myocardial hypertrophy is a cardiac compensatory change responding to the outside stimulus, demonstrated by increased myocardial cells volume, myocardial interstitial cell proliferation, increased extracellular matrix and other pathological changes. Long-term myocardial hypertrophy can lead to an increased myocardial oxygen consumption and reduce compliance of the heart eventually leading to heart failure or sudden death. Previous studies have shown that high-salt diet can lead to myocardial hypertrophy independent of blood pressure, thereby increasing the incidence of cardiovascular events (<xref ref-type="bibr" rid="B24">Mak et al., 2013</xref>; <xref ref-type="bibr" rid="B16">Katayama et al., 2014</xref>). However, the mechanism underlying high-salt-induced myocardial hypertrophy has not been clear yet.</p>
<p>Many studies showed that H<sub>2</sub>S had an important protective effect on a variety of cardiovascular diseases (<xref ref-type="bibr" rid="B30">Qipshidze et al., 2012</xref>; <xref ref-type="bibr" rid="B27">Nicholson et al., 2013</xref>; <xref ref-type="bibr" rid="B29">Polhemus et al., 2013</xref>; <xref ref-type="bibr" rid="B28">Pan et al., 2014</xref>). H<sub>2</sub>S could reduce myocardial remodeling caused by myocardial ischemia by increasing the activity of natriuretic peptide and improve myocardial remodeling by inhibiting myocardial fibroblast cell migration to myocardial fibroblasts (<xref ref-type="bibr" rid="B19">Lilyanna et al., 2015</xref>; <xref ref-type="bibr" rid="B43">Zhang et al., 2015</xref>). In smoking rat model and heart failure rat model, H<sub>2</sub>S also reduced myocardial remodeling and improved cardiac function (<xref ref-type="bibr" rid="B26">Mishra et al., 2010</xref>; <xref ref-type="bibr" rid="B44">Zhou et al., 2015</xref>). Our previous study showed that H<sub>2</sub>S could alleviate high salt-induced aortic remodeling and renal injury (<xref ref-type="bibr" rid="B14">Huang et al., 2015</xref>, <xref ref-type="bibr" rid="B15">2016</xref>), but the protective effect of H<sub>2</sub>S on high-salt-induced myocardial hypertrophy was unclear. In the present study, we found that high-salt diet significantly reduced H<sub>2</sub>S content and CBS mRNA and protein expressions of myocardial tissues with significant myocardial hypertrophy in Dahl rats. At the same time, we also found that the mRNA expression of CSE was also downregulated, while no change of protein expression of CSE was observed in Dahl rats with high-salt intake. The regulation on the post-trancriptional level or translational level might lead to the differences in the mRNA and protein expressions of CSE in Dahl rats with high-salt intake (<xref ref-type="bibr" rid="B10">Greenbaum et al., 2003</xref>). However, there was no significant change in the above indexes in myocardial tissues of SD rats fed with high salt. The results showed that the down-regulation of H<sub>2</sub>S/CBS pathway induced by high-salt diet was closely correlated with myocardial hypertrophy. After H<sub>2</sub>S treatment, myocardial hypertrophy was significantly reduced in Dahl + HS group. The results demonstrated that H<sub>2</sub>S significantly improved high-salt-induced myocardial hypertrophy. In contrast, myocardial hypertrophy became obvious in SD rats treated with HA, an inhibitor of CBS, as compared with SD + HS rats without HA treatment. Taken together, the results demonstrated that H<sub>2</sub>S could attenuate high salt-induced myocardial hypertrophy.</p>
<p>However, protective mechanism by which H<sub>2</sub>S attenuated high salt-induced myocardial hypertrophy was unclear. Oxidative stress is a kind of pathological state, which refers to excessive oxygen free radicals and (or) intracellular antioxidant defense system damage, leading to excessive accumulation of oxygen free radicals and related metabolites, resulting in a variety of toxic effects on cells. Reactive oxygen species (ROS) include superoxide anion, &#x22C5;OH and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). Reactive nitrogen species (RNS) include nitric oxide (NO), nitrogen dioxide (NO<sub>2</sub>), and peroxynitrite (ONOO<sup>-</sup>). The antioxidant system in the body includes the following enzymes, such as SOD, CAT, GSH-Px and a variety of vitamins. Studies have shown that oxidative stress plays an important role in the formation of myocardial hypertrophy. Enhanced NADH/NADPH oxidase activity and increased production of ROS could lead to myocardial hypertrophy, and also the application of antioxidants such as GSH-Px could significantly reduce myocardial hypertrophy (<xref ref-type="bibr" rid="B1">Amin et al., 2001</xref>; <xref ref-type="bibr" rid="B23">MacCarthy et al., 2001</xref>; <xref ref-type="bibr" rid="B33">Shiomi et al., 2004</xref>). Studies showed that oxidative stress was involved in myocardial hypertrophy induced by high salt (<xref ref-type="bibr" rid="B40">Yu et al., 1998</xref>; <xref ref-type="bibr" rid="B7">Gao et al., 2011</xref>; <xref ref-type="bibr" rid="B37">Wu et al., 2016</xref>). While, H<sub>2</sub>S was reported to be an important anti-oxidant and play anti-oxidative role in the nervous system, cardiovascular system, respiratory system, and renal tissues, etc (<xref ref-type="bibr" rid="B8">Geng et al., 2004a</xref>; <xref ref-type="bibr" rid="B41">Yu et al., 2015</xref>; <xref ref-type="bibr" rid="B15">Huang et al., 2016</xref>; <xref ref-type="bibr" rid="B42">Zhang et al., 2016</xref>). However, whether H<sub>2</sub>S inhibited oxidative stress injury in the high-salt-stimulated myocardial hypertrophy was not fully understood.</p>
<p>Therefore, we detected oxidative stress and antioxidant stress indices in the myocardial tissues to see if the inhibitory effect of H<sub>2</sub>S on myocardial hypertrophy was related to the increase of anti-oxidative capacity. We found that high-salt significantly induced excessive oxidative stress in myocardial tissues of Dahl rats as demonstrated by the decreased levels of T-AOC, CO and GSH, the activities of antioxidant enzyme and protein expressions of SOD1 and SOD2, and elevated levels of &#x22C5;OH, MDA, and GSSG. The above results indicated that high-salt induced oxidative stress injury of myocardial tissues in Dahl rats. The results of Dahl rats treated with NaHS showed that levels of T-AOC, CO and GSH, the activities of CAT, GSH-Px and SOD, and protein expressions of SOD1 and SOD2 in the myocardial tissues were increased with decreased the contents of &#x22C5;OH, MDA, and GSSG. While HA upregulated all detected oxidative stress indices but downregulated all tested anti-oxidant stress indices in the myocardial tissues of SD rats with high-salt diet, mimicking the effect of high salt on oxidative stress injury in the myocardial tissues of Dahl rats. Therefore, the study demonstrated that H<sub>2</sub>S attenuated high-salt-induced myocardial hypertrophy in association with inhibiting oxidative stress of myocardial tissues in salt-sensitive rats.</p>
<p>The present study also had limitations. We demonstrated the effect of H<sub>2</sub>S on high salt-induced myocardial hypertrophy by using NaHS, an H<sub>2</sub>S donor, but we did not use different well known H<sub>2</sub>S donors and different experimental models to illuminate the beneficial effects of H<sub>2</sub>S on high salt-induced myocardial damage. It would be necessary and important to further explore the H<sub>2</sub>S-based treatment for high salt-induced vascular and myocardial damage in experimental and even clinical studies.</p>
</sec>
<sec><title>Conclusion</title>
<p>In summary, the study demonstrated that H<sub>2</sub>S could attenuate high-salt-induced myocardial hypertrophy in Dahl rats. The protective mechanism might be related to the enhancement of antioxidant capacity and the inhibition of oxidative stress of myocardial tissues.</p>
</sec>
<sec><title>Author Contributions</title>
<p>PH, CT, HJ and JD conceived and designed the experiment. PH, ZS, and WY performed the experiment, PH analyzed data and wrote the paper. YH, HJ, CT, and JD revised the manuscript. All authors have contributed to the final version and approved the publication of the final manuscript.</p>
</sec>
<sec><title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>The authors sincerely thank the following funds for their support to this project: the National Basic Research Program of the People&#x2019;s Republic of China (2013CB933801), the National Natural Science Foundation of China (81622004, 81500325), and the Grant Teacher and Doctor Training Base of the Ministry of Education of the People&#x2019;s Republic of China (20130001120047).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname> <given-names>J. K.</given-names></name> <name><surname>Xiao</surname> <given-names>L.</given-names></name> <name><surname>Pimentel</surname> <given-names>D. R.</given-names></name> <name><surname>Pagano</surname> <given-names>P. J.</given-names></name> <name><surname>Singh</surname> <given-names>K.</given-names></name> <name><surname>Sawyer</surname> <given-names>D. B.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Reactive oxygen species mediate alpha adrenergic receptor-stimulated hypertrophy in adult rat vetricular myocytes.</article-title> <source><italic>J. Mol. Cell. Cardiol.</italic></source> <volume>33</volume> <fpage>131</fpage>&#x2013;<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1006/jmcc.2000.1285</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chamarthi</surname> <given-names>B.</given-names></name> <name><surname>Williams</surname> <given-names>J. S.</given-names></name> <name><surname>Williams</surname> <given-names>G. H.</given-names></name></person-group> (<year>2010</year>). <article-title>A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II.</article-title> <source><italic>J. Hypertens.</italic></source> <volume>28</volume> <fpage>1020</fpage>&#x2013;<lpage>1026</lpage>. <pub-id pub-id-type="doi">10.1097/HJH.0b013e3283375974</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cramariuc</surname> <given-names>D.</given-names></name> <name><surname>Gerdts</surname> <given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>Epidemiology of left ventricular hypertrophy in hypertension: implications for the clinic.</article-title> <source><italic>Expert Rev. Cardiovasc. Ther.</italic></source> <volume>14</volume> <fpage>915</fpage>&#x2013;<lpage>926</lpage>. <pub-id pub-id-type="doi">10.1080/14779072.2016.1186542</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname> <given-names>B.</given-names></name> <name><surname>Schantz</surname> <given-names>J. T.</given-names></name> <name><surname>Haigh</surname> <given-names>R.</given-names></name> <name><surname>Wood</surname> <given-names>M. E.</given-names></name> <name><surname>Moore</surname> <given-names>P. K.</given-names></name> <name><surname>Viner</surname> <given-names>N.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Inducible hydrogen sulfide synthesis in chondrocytes and mesenchymal progenitor cells: is H2S a novel cytoprotective mediator in the inflamed joint?</article-title> <source><italic>J. Cell. Mol. Med.</italic></source> <volume>16</volume> <fpage>896</fpage>&#x2013;<lpage>910</lpage>. <pub-id pub-id-type="doi">10.1111/j.1582-4934.2011.01357.x</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galderisi</surname> <given-names>M.</given-names></name> <name><surname>Anderson</surname> <given-names>K. M.</given-names></name> <name><surname>Wilson</surname> <given-names>P. M.</given-names></name> <name><surname>Levy</surname> <given-names>D.</given-names></name></person-group> (<year>1991</year>). <article-title>Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study).</article-title> <source><italic>Am. J. Cardiol.</italic></source> <volume>68</volume> <fpage>85</fpage>&#x2013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1016/0002-9149(91)90716-X</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gallo</surname> <given-names>A.</given-names></name> <name><surname>Taquini</surname> <given-names>C. M.</given-names></name> <name><surname>Font&#x00E1;n</surname> <given-names>M.</given-names></name> <name><surname>Campissi</surname> <given-names>R.</given-names></name> <name><surname>Kuraja</surname> <given-names>I.</given-names></name> <name><surname>Gomez Llamb&#x00ED;</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>1990</year>). <article-title>Sodium intake modulates the development of cardiac hypertrophy in two-kidney, one clip rats.</article-title> <source><italic>Hypertension</italic></source> <volume>15</volume> <fpage>I157</fpage>&#x2013;<lpage>I160</lpage>. <pub-id pub-id-type="doi">10.1161/01.HYP.15.2_Suppl.I157</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>F.</given-names></name> <name><surname>Han</surname> <given-names>Z. Q.</given-names></name> <name><surname>Zhou</surname> <given-names>X.</given-names></name> <name><surname>Shi</surname> <given-names>R.</given-names></name> <name><surname>Dong</surname> <given-names>Y.</given-names></name> <name><surname>Jiang</surname> <given-names>T. M.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>High salt intake accelerated cardiac remodeling in spontaneously hypertension rats: time window of left ventricular functional transition and its relation to salt-loading doses.</article-title> <source><italic>Clin. Exp. Hypertens.</italic></source> <volume>33</volume> <fpage>492</fpage>&#x2013;<lpage>499</lpage>. <pub-id pub-id-type="doi">10.3109/10641963.2010.551795</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geng</surname> <given-names>B.</given-names></name> <name><surname>Chang</surname> <given-names>L.</given-names></name> <name><surname>Pan</surname> <given-names>C.</given-names></name> <name><surname>Qi</surname> <given-names>Y.</given-names></name> <name><surname>Zhao</surname> <given-names>J.</given-names></name> <name><surname>Pang</surname> <given-names>Y.</given-names></name><etal/></person-group> (<year>2004a</year>). <article-title>Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol.</article-title> <source><italic>Biochem. Biophys. Res. Commun.</italic></source> <volume>318</volume> <fpage>756</fpage>&#x2013;<lpage>763</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2004.04.094</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geng</surname> <given-names>B.</given-names></name> <name><surname>Yang</surname> <given-names>J.</given-names></name> <name><surname>Qi</surname> <given-names>Y.</given-names></name> <name><surname>Zhao</surname> <given-names>J.</given-names></name> <name><surname>Pang</surname> <given-names>Y.</given-names></name> <name><surname>Du</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2004b</year>). <article-title>H<sub>2</sub>S generated by heart in rat and its effects on cardiac function.</article-title> <source><italic>Biochem. Biophys. Res. Commun.</italic></source> <volume>313</volume> <fpage>362</fpage>&#x2013;<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2003.11.130</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Greenbaum</surname> <given-names>D.</given-names></name> <name><surname>Colangelo</surname> <given-names>C.</given-names></name> <name><surname>Williams</surname> <given-names>K.</given-names></name> <name><surname>Gerstein</surname> <given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>Comparing protein abundance and mRNA expression levels on a genomic scale.</article-title> <source><italic>Genome Biol.</italic></source> <volume>4</volume> <issue>117</issue>. <pub-id pub-id-type="doi">10.1186/gb-2003-4-9-117</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>Y.</given-names></name> <name><surname>Qin</surname> <given-names>J.</given-names></name> <name><surname>Chang</surname> <given-names>X.</given-names></name> <name><surname>Yang</surname> <given-names>Z.</given-names></name> <name><surname>Tang</surname> <given-names>X.</given-names></name> <name><surname>Du</surname> <given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>Hydrogen sulfide may improve the hippocampal damage induced by recurrent febrile seizures in rats.</article-title> <source><italic>Biochem. Biophys. Res. Commun.</italic></source> <volume>327</volume> <fpage>431</fpage>&#x2013;<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2004.12.028</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harmsen</surname> <given-names>E.</given-names></name> <name><surname>Leenen</surname> <given-names>F. H.</given-names></name></person-group> (<year>1992</year>). <article-title>Dietary sodium induced cardiac hypertrophy.</article-title> <source><italic>Can. J. Physiol. Pharmacol.</italic></source> <volume>70</volume> <fpage>580</fpage>&#x2013;<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1139/y92-073</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>F. J.</given-names></name> <name><surname>Macgregor</surname> <given-names>G. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Salt intake, plasma sodium, and worldwide salt reduction.</article-title> <source><italic>Ann. Med.</italic></source> <volume>44</volume> <fpage>S127</fpage>&#x2013;<lpage>S137</lpage>. <pub-id pub-id-type="doi">10.3109/07853890.2012.660495</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>P.</given-names></name> <name><surname>Chen</surname> <given-names>S.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>Yao</surname> <given-names>Q.</given-names></name> <name><surname>Huang</surname> <given-names>Y.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Down-regulated CBS/H<sub>2</sub>S pathway is involved in high-salt-induced hypertension in Dahl rats.</article-title> <source><italic>Nitric Oxide</italic></source> <volume>46</volume> <fpage>192</fpage>&#x2013;<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1016/j.niox.2015.01.004</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>P.</given-names></name> <name><surname>Shen</surname> <given-names>Z.</given-names></name> <name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>Huang</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>S.</given-names></name> <name><surname>Yu</surname> <given-names>W.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Hydrogen sulfide inhibits high-salt diet-induced renal oxidative stress and kidney injury in Dahl rats.</article-title> <source><italic>Oxid. Med. Cell. Longev.</italic></source> <volume>2016</volume>:<issue>2807490</issue>. <pub-id pub-id-type="doi">10.1155/2016/2807490</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katayama</surname> <given-names>I. A.</given-names></name> <name><surname>Pereira</surname> <given-names>R. C.</given-names></name> <name><surname>Dopona</surname> <given-names>E. P.</given-names></name> <name><surname>Shimizu</surname> <given-names>M. H.</given-names></name> <name><surname>Furukawa</surname> <given-names>L. N.</given-names></name> <name><surname>Oliveira</surname> <given-names>I. B.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>High-salt intake induces cardiomyocyte hypertrophy in rats in response to local angiotensin II type 1 receptor activation.</article-title> <source><italic>J. Nutr.</italic></source> <volume>144</volume> <fpage>1571</fpage>&#x2013;<lpage>1578</lpage>. <pub-id pub-id-type="doi">10.3945/jn.114.192054</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le Corvoisier</surname> <given-names>P.</given-names></name> <name><surname>Adamy</surname> <given-names>C.</given-names></name> <name><surname>Sambin</surname> <given-names>L.</given-names></name> <name><surname>Crozatier</surname> <given-names>B.</given-names></name> <name><surname>Berdeaux</surname> <given-names>A.</given-names></name> <name><surname>Michel</surname> <given-names>J. B.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>The cardiac renin-angiotension system is responsible for high-salt diet-induced left ventricular hypertrophy in mice.</article-title> <source><italic>Eur. J. Heart Fail.</italic></source> <volume>12</volume> <fpage>1171</fpage>&#x2013;<lpage>1178</lpage>. <pub-id pub-id-type="doi">10.1093/eurjhf/hfq146</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>X.</given-names></name> <name><surname>Shimada</surname> <given-names>T.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Zhou</surname> <given-names>X.</given-names></name> <name><surname>Zhao</surname> <given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>Ultrastructure changes of cardiac lyphatics during cardiac fibrosis in hypertensive rats.</article-title> <source><italic>Anat. Rec.</italic></source> <volume>292</volume> <fpage>1612</fpage>&#x2013;<lpage>1618</lpage>. <pub-id pub-id-type="doi">10.1002/ar.20943</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lilyanna</surname> <given-names>S.</given-names></name> <name><surname>Peh</surname> <given-names>M. T.</given-names></name> <name><surname>Liew</surname> <given-names>O. W.</given-names></name> <name><surname>Wang</surname> <given-names>P.</given-names></name> <name><surname>Moore</surname> <given-names>P. K.</given-names></name> <name><surname>Richards</surname> <given-names>A. M.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>GYY4137 attenuates remodeling, preserves cardiac function and modulates the natriuretic peptide response to ischemia.</article-title> <source><italic>J. Mol. Cell. Cardiol.</italic></source> <volume>87</volume> <fpage>27</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2015.07.028</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y. H.</given-names></name> <name><surname>Lu</surname> <given-names>M.</given-names></name> <name><surname>Xie</surname> <given-names>Z. Z.</given-names></name> <name><surname>Hua</surname> <given-names>F.</given-names></name> <name><surname>Xie</surname> <given-names>L.</given-names></name> <name><surname>Gao</surname> <given-names>J. H.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Hydrogen sulfide prevents heart failure development via inhibition of renin release from mast cells in isoproterenol-treated rats.</article-title> <source><italic>Antioxid. Redox Signal.</italic></source> <volume>20</volume> <fpage>759</fpage>&#x2013;<lpage>769</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2012.4888</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>F.</given-names></name> <name><surname>Xing</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Dong</surname> <given-names>S.</given-names></name> <name><surname>Zhao</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Exogenous hydrogen sulfide prevents cardiomyocyte apoptosis from cardiac hypertrophy induced by isoproterenol.</article-title> <source><italic>Mol. Cell. Biochem.</italic></source> <volume>381</volume> <fpage>41</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1007/s11010-013-1686-7</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>L.</given-names></name> <name><surname>Liu</surname> <given-names>D.</given-names></name> <name><surname>Tang</surname> <given-names>C.</given-names></name> <name><surname>Du</surname> <given-names>J.</given-names></name> <name><surname>Liu</surname> <given-names>A. D.</given-names></name> <name><surname>Holmberg</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Sulfur dioxide upregulates the inhibited endogenous hydrogen sulfide pathway in rats with pulmonary hypertension induced by high pulmonary blood flow.</article-title> <source><italic>Biochem. Biophys. Res. Commun.</italic></source> <volume>433</volume> <fpage>519</fpage>&#x2013;<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2013.03.014</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacCarthy</surname> <given-names>P. A.</given-names></name> <name><surname>Grieve</surname> <given-names>D. J.</given-names></name> <name><surname>Li</surname> <given-names>J. M.</given-names></name> <name><surname>Dunster</surname> <given-names>C.</given-names></name> <name><surname>Kelly</surname> <given-names>F. J.</given-names></name> <name><surname>Shah</surname> <given-names>A. M.</given-names></name></person-group> (<year>2001</year>). <article-title>Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase.</article-title> <source><italic>Circulation</italic></source> <volume>104</volume> <fpage>2967</fpage>&#x2013;<lpage>2974</lpage>. <pub-id pub-id-type="doi">10.1161/hc4901.100382</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mak</surname> <given-names>G. S.</given-names></name> <name><surname>Sawaya</surname> <given-names>H.</given-names></name> <name><surname>Khan</surname> <given-names>A. M.</given-names></name> <name><surname>Arora</surname> <given-names>P.</given-names></name> <name><surname>Martinez</surname> <given-names>A.</given-names></name> <name><surname>Ryan</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Effects of subacute dietary salt intake and acute volume expansion on diastolic function in young normotensive individuals.</article-title> <source><italic>Eur. Heart J. Cardiovasc. Imaging</italic></source> <volume>14</volume> <fpage>1092</fpage>&#x2013;<lpage>1098</lpage>. <pub-id pub-id-type="doi">10.1093/ehjci/jet036</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mimran</surname> <given-names>A.</given-names></name> <name><surname>du Cailar</surname> <given-names>G.</given-names></name></person-group> (<year>2008</year>). <article-title>Dietary sodium: the dark horse amongst cardiovascular and renal risk factors.</article-title> <source><italic>Nephrol. Dial. Transplant.</italic></source> <volume>23</volume> <fpage>2138</fpage>&#x2013;<lpage>2141</lpage>. <pub-id pub-id-type="doi">10.1093/ndt/gfn160</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname> <given-names>P. K.</given-names></name> <name><surname>Tyagi</surname> <given-names>N.</given-names></name> <name><surname>Sen</surname> <given-names>U.</given-names></name> <name><surname>Givvimani</surname> <given-names>S.</given-names></name> <name><surname>Tyagi</surname> <given-names>S. C.</given-names></name></person-group> (<year>2010</year>). <article-title>H<sub>2</sub>S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure.</article-title> <source><italic>Am. J. Physiol. Heart Circ. Physiol.</italic></source> <volume>298</volume> <fpage>H451</fpage>&#x2013;<lpage>H456</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00682.2009</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname> <given-names>C. K.</given-names></name> <name><surname>Lambert</surname> <given-names>J. P.</given-names></name> <name><surname>Molkentin</surname> <given-names>J. D.</given-names></name> <name><surname>Sadoshima</surname> <given-names>J.</given-names></name> <name><surname>Calvert</surname> <given-names>J. W.</given-names></name></person-group> (<year>2013</year>). <article-title>Thioredoxin 1 is essential for sodium sulfide-mediated cardioprotection in the setting of heart failure.</article-title> <source><italic>Arterioscler. Thromb. Vasc. Biol.</italic></source> <volume>2013</volume> <fpage>744</fpage>&#x2013;<lpage>751</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.112.300484</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname> <given-names>L. L.</given-names></name> <name><surname>Wang</surname> <given-names>X. L.</given-names></name> <name><surname>Wang</surname> <given-names>X. L.</given-names></name> <name><surname>Zhu</surname> <given-names>Y. Z.</given-names></name></person-group> (<year>2014</year>). <article-title>Sodium hydrosulfide prevents myocardial dysfunction through modulation of extracellular matrix accumulation and vascular density.</article-title> <source><italic>Int. J. Mol. Sci.</italic></source> <volume>15</volume> <fpage>23212</fpage>&#x2013;<lpage>23226</lpage>. <pub-id pub-id-type="doi">10.3390/ijms151223212</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Polhemus</surname> <given-names>D. J.</given-names></name> <name><surname>Kondo</surname> <given-names>K.</given-names></name> <name><surname>Bhushan</surname> <given-names>S.</given-names></name> <name><surname>Bir</surname> <given-names>S. C.</given-names></name> <name><surname>Kevil</surname> <given-names>C. G.</given-names></name> <name><surname>Murohara</surname> <given-names>T.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Hydrogen sulfide attenuates cardiac dysfunction after heart failure via induction of angiogensis.</article-title> <source><italic>Circ. Heart Fail.</italic></source> <volume>6</volume> <fpage>1077</fpage>&#x2013;<lpage>1086</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCHEARTFAILURE.113.000299</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qipshidze</surname> <given-names>N.</given-names></name> <name><surname>Metreveli</surname> <given-names>N.</given-names></name> <name><surname>Mishra</surname> <given-names>P. K.</given-names></name> <name><surname>Lominadze</surname> <given-names>D.</given-names></name> <name><surname>Tyagi</surname> <given-names>S. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Hydrogen sulfide mitigates cardiac remodeling during myocardial infarction via improvement of angiogenesis.</article-title> <source><italic>Int. J. Biol. Sci.</italic></source> <volume>8</volume> <fpage>430</fpage>&#x2013;<lpage>441</lpage>. <pub-id pub-id-type="doi">10.7150/ijbs.3632</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname> <given-names>Y.</given-names></name> <name><surname>Shen</surname> <given-names>Z.</given-names></name> <name><surname>Luo</surname> <given-names>S.</given-names></name> <name><surname>Guo</surname> <given-names>W.</given-names></name> <name><surname>Zhu</surname> <given-names>Y. Z.</given-names></name></person-group> (<year>2015</year>). <article-title>The cardioprotective effects of hydrogen sulfide in heart diseases: from molecular mechanisms to therapeutic potential.</article-title> <source><italic>Oxid. Med. Cell. Longev.</italic></source> <volume>2015</volume>:<issue>925167</issue>. <pub-id pub-id-type="doi">10.1155/2015/925167</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>Y. X.</given-names></name> <name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Zhu</surname> <given-names>Y. Z.</given-names></name> <name><surname>Huang</surname> <given-names>G. Y.</given-names></name> <name><surname>Moore</surname> <given-names>P. K.</given-names></name> <name><surname>Huang</surname> <given-names>S. H.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats.</article-title> <source><italic>Am. J. Physiol. Heart Circ. Physiol.</italic></source> <volume>293</volume> <fpage>H2093</fpage>&#x2013;<lpage>H2100</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00088.2007</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shiomi</surname> <given-names>T.</given-names></name> <name><surname>Tsutsui</surname> <given-names>H.</given-names></name> <name><surname>Matsusaka</surname> <given-names>H.</given-names></name> <name><surname>Murakami</surname> <given-names>K.</given-names></name> <name><surname>Hayashidani</surname> <given-names>S.</given-names></name> <name><surname>Ikeuchi</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.</article-title> <source><italic>Circulation</italic></source> <volume>109</volume> <fpage>544</fpage>&#x2013;<lpage>549</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.0000109701.77059.E9</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sodha</surname> <given-names>N. R.</given-names></name> <name><surname>Clements</surname> <given-names>R. T.</given-names></name> <name><surname>Feng</surname> <given-names>J.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Bianchi</surname> <given-names>C.</given-names></name> <name><surname>Horvath</surname> <given-names>E. M.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury.</article-title> <source><italic>J. Thorac. Cardiovasc. Surg.</italic></source> <volume>138</volume> <fpage>977</fpage>&#x2013;<lpage>984</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtcvs.2008.08.074</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Su</surname> <given-names>Y. W.</given-names></name> <name><surname>Liang</surname> <given-names>C.</given-names></name> <name><surname>Jin</surname> <given-names>H. F.</given-names></name> <name><surname>Tang</surname> <given-names>X. Y.</given-names></name> <name><surname>Han</surname> <given-names>W.</given-names></name> <name><surname>Chai</surname> <given-names>L. J.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Hydrogen sulfide regulates cardiac function and structure in adriamycin-induced cardiomyopathy.</article-title> <source><italic>Circ. J.</italic></source> <volume>73</volume> <fpage>741</fpage>&#x2013;<lpage>749</lpage>. <pub-id pub-id-type="doi">10.1253/circj.CJ-08-0636</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname> <given-names>H.</given-names></name> <name><surname>Zhang</surname> <given-names>R.</given-names></name> <name><surname>Jin</surname> <given-names>H.</given-names></name> <name><surname>Liu</surname> <given-names>D.</given-names></name> <name><surname>Tang</surname> <given-names>X.</given-names></name> <name><surname>Tang</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Hydrogen sulfide attenuates hyperhomocystinemia-induced cardiomyocytic endoplasmic reticulum stress in rats.</article-title> <source><italic>Antioxid. Redox Signal.</italic></source> <volume>12</volume> <fpage>1079</fpage>&#x2013;<lpage>1091</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2009.2898</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>H.</given-names></name> <name><surname>Chen</surname> <given-names>L.</given-names></name> <name><surname>Xie</surname> <given-names>J.</given-names></name> <name><surname>Li</surname> <given-names>R.</given-names></name> <name><surname>Li</surname> <given-names>G. N.</given-names></name> <name><surname>Chen</surname> <given-names>Q. H.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Periostin expression induced by oxidative stress contributes to myocardial fibrosis in a rat model of high salt-induced hypertension.</article-title> <source><italic>Mol. Med. Rep.</italic></source> <volume>14</volume> <fpage>776</fpage>&#x2013;<lpage>782</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2016.5308</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>Y.</given-names></name> <name><surname>Feng</surname> <given-names>W.</given-names></name> <name><surname>Zhang</surname> <given-names>H.</given-names></name> <name><surname>Li</surname> <given-names>S.</given-names></name> <name><surname>Wang</surname> <given-names>D.</given-names></name> <name><surname>Pan</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Ca<sup>2+</sup>-regulatory proteins in cardiomyocytes from the right ventricle in children with congenital heart disease.</article-title> <source><italic>J. Transl. Med.</italic></source> <volume>10</volume>:<issue>67</issue>. <pub-id pub-id-type="doi">10.1186/1479-5876-10-67</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>F.</given-names></name> <name><surname>Liu</surname> <given-names>Z.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>Z.</given-names></name> <name><surname>Yu</surname> <given-names>H.</given-names></name> <name><surname>Wang</surname> <given-names>Q.</given-names></name></person-group> (<year>2014</year>). <article-title>Hydrogen sulfide endothelin-induced myocardial hypertrophy in rats and the mechanism involved.</article-title> <source><italic>Cell Biochem. Biophys.</italic></source> <volume>70</volume> <fpage>1683</fpage>&#x2013;<lpage>1686</lpage>. <pub-id pub-id-type="doi">10.1007/s12013-014-0113-3</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>H. C.</given-names></name> <name><surname>Burrell</surname> <given-names>L. M.</given-names></name> <name><surname>Black</surname> <given-names>M. J.</given-names></name> <name><surname>Wu</surname> <given-names>L. L.</given-names></name> <name><surname>Dilley</surname> <given-names>R. J.</given-names></name> <name><surname>Cooper</surname> <given-names>M. E.</given-names></name><etal/></person-group> (<year>1998</year>). <article-title>Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats.</article-title> <source><italic>Circulation</italic></source> <volume>98</volume> <fpage>2621</fpage>&#x2013;<lpage>2628</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.98.23.2621</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>Q.</given-names></name> <name><surname>Lu</surname> <given-names>Z.</given-names></name> <name><surname>Tao</surname> <given-names>L.</given-names></name> <name><surname>Yang</surname> <given-names>L.</given-names></name> <name><surname>Guo</surname> <given-names>Y.</given-names></name> <name><surname>Sun</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>ROS-dependent neuroprotective effect of NaHS in ischemia brain injury involves the PARP/AIF pathway.</article-title> <source><italic>Cell. Physiol. Biochem.</italic></source> <volume>36</volume> <fpage>1539</fpage>&#x2013;<lpage>1551</lpage>. <pub-id pub-id-type="doi">10.1159/000430317</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>H. X.</given-names></name> <name><surname>Liu</surname> <given-names>S. J.</given-names></name> <name><surname>Tang</surname> <given-names>X. L.</given-names></name> <name><surname>Duan</surname> <given-names>G. L.</given-names></name> <name><surname>Ni</surname> <given-names>X.</given-names></name> <name><surname>Zhu</surname> <given-names>X. Y.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>H<sub>2</sub>S attenuated LPS-induced acute lung injury by reducing oxidative/nitrative stress and inflammation.</article-title> <source><italic>Cell. Physiol. Biochem.</italic></source> <volume>40</volume> <fpage>1603</fpage>&#x2013;<lpage>1612</lpage>. <pub-id pub-id-type="doi">10.1159/000453210</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Li</surname> <given-names>H.</given-names></name> <name><surname>Yuan</surname> <given-names>L.</given-names></name> <name><surname>Wang</surname> <given-names>L.</given-names></name> <name><surname>Wu</surname> <given-names>B.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Hydrogen sulfide suppresses transforming growth factor-&#x03B2;1-induced differentiation of human cardiacfibroblasts into myofibroblasts.</article-title> <source><italic>Sci. China Life Sci.</italic></source> <volume>58</volume> <fpage>1126</fpage>&#x2013;<lpage>1134</lpage>. <pub-id pub-id-type="doi">10.1007/s11427-015-4904-6</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>X.</given-names></name> <name><surname>Zhao</surname> <given-names>L.</given-names></name> <name><surname>Mao</surname> <given-names>J.</given-names></name> <name><surname>Huang</surname> <given-names>J.</given-names></name> <name><surname>Chen</surname> <given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Antioxidant effects of hydrogen sulfide on left ventricular remodeling in smoking rats are mediated via PI3K/Akt-dependent activation of Nrf2.</article-title> <source><italic>Toxicol. Sci.</italic></source> <volume>144</volume> <fpage>197</fpage>&#x2013;<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kfu272</pub-id></citation></ref>
</ref-list>
</back>
</article>